InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Gros David-Alexandre C, Chairman & CEO. Insider active across 1 companies, notably Eledon Pharmaceuticals, Inc.. Aggregated, 6 reports have been published. Total volume traded: €98k. The latest transaction was filed on 20 December 2021 (Acquisition). Regulator: SEC (Form 4). All data is free.
Declarations6 total
€7,9692,000 shares@ €3.984516.3% of flow
Common Stock
SEC:0000899243-21-049171·
Ideal exit: 16 Sept 2022 (T+270)
€7,9692,000 shares@ €3.98450.0070% mcap8.1% of flow
Common Stock
SEC:0000899243-21-049171:0·
Ideal exit: 16 Sept 2022 (T+270)
€21,2134,000 shares@ €5.303343.4% of flow
Common Stock
SEC:0001209191-21-052519·
Ideal exit: 14 May 2022 (T+270)
€21,2134,000 shares@ €5.30330.019% mcap21.7% of flow
Common Stock
SEC:0001209191-21-052519:0·
Ideal exit: 14 May 2022 (T+270)
€19,7263,000 shares@ €6.575340.3% of flow
Common Stock
SEC:0000899243-21-022998·
Ideal exit: 6 Mar 2022 (T+270)
€19,7263,000 shares@ €6.57530.017% mcap20.2% of flow
Common Stock
SEC:0000899243-21-022998:0·
Ideal exit: 6 Mar 2022 (T+270)
6 of 6 declarations
About Gros David-Alexandre C
David-Alexandre C. Gros is Chief Executive Officer at Eledon Pharmaceuticals, Inc. He leads the company and oversees all operations, ensuring compliance and financial performance. His leadership is essential for the growth and development of the organization.
